Pregled bibliografske jedinice broj: 684930
Echocardiography parameters before therapy cannot predict cardiotoxicity caused by Trastuzumab
Echocardiography parameters before therapy cannot predict cardiotoxicity caused by Trastuzumab // Cardiologia croatica, 8 (5-6) (2013), 169-169 (podatak o recenziji nije dostupan, članak, ostalo)
CROSBI ID: 684930 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Echocardiography parameters before therapy cannot predict cardiotoxicity caused by Trastuzumab
Autori
Gabrić, Ivo Darko ; Vazdar, Ljubica ; Planinc, Danijel ; Vinter, Ozren ; Trbušić, Matijas ; Bulj, Nikola ; Pintarić, Hrvoje.
Izvornik
Cardiologia croatica (1848-543X) 8 (5-6)
(2013);
169-169
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, ostalo
Ključne riječi
cardiotoxicity; trastuzumab
Sažetak
Cardiotoxicity is the most important side effect of trastuzumab, humanized monoclonal antibody to the HER2 protein, in use for imunotherapy of breast cancer.In our study, 130 patients (pts) with non- metastatic breast cancer were treated for one year, in adjuvant therapy, with trastuzumab. Patients were divided in two groups:51 pts with proven cardiotoxicity side effect were assorted into group A, and the control group B with 79 pts who didn´t have cardiotoxicity.Initial lower left ventricular ejection fraction (LVEF) were found to be a risk factor for the development of cardiotoxicity.We did not determine that any of the echocardiography parameters prior to the trastuzumab therapy was a significant risk factor for the development of cardiotoxicity.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Klinika za tumore
Profili:
Ljubica Vazdar
(autor)
Hrvoje Pintarić
(autor)
Ivo Darko Gabrić
(autor)
Nikola Bulj
(autor)
Danijel Planinc
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- SCI-EXP, SSCI i/ili A&HCI